Dimensional Fund Advisors’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.9M Buy
2,757,158
+504,553
+22% +$5.23M ﹤0.01% 1904
2025
Q4
$27.8M Buy
2,252,605
+112,265
+5% +$1.2M 0.01% 1812
2025
Q3
$18.9M Buy
2,140,340
+291,308
+16% +$2.27M ﹤0.01% 2014
2025
Q2
$11.8M Buy
1,849,032
+252,395
+16% +$1.44M ﹤0.01% 2215
2025
Q1
$7.76M Buy
1,596,637
+492,579
+45% +$4.08M ﹤0.01% 2357
2024
Q4
$10.6M Buy
1,104,058
+444,790
+67% +$4.08M ﹤0.01% 2284
2024
Q3
$5.5M Buy
659,268
+418,500
+174% +$3.8M ﹤0.01% 2499
2024
Q2
$1.64M Sell
240,768
-141,476
-37% -$609K ﹤0.01% 2807
2024
Q1
$967K Sell
382,244
-275,976
-42% -$622K ﹤0.01% 2929
2023
Q4
$1.58M Sell
658,220
-143,383
-18% -$337K ﹤0.01% 2836
2023
Q3
$2.73M Sell
801,603
-687,982
-46% -$3.81M ﹤0.01% 2690
2023
Q2
$10.9M Sell
1,489,585
-321,344
-18% -$2.98M ﹤0.01% 2220
2023
Q1
$18.8M Sell
1,810,929
-28,232
-2% -$341K 0.01% 1936
2022
Q4
$21.7K Sell
1,839,161
-83,069
-4% -$1.29M 0.01% 1835
2022
Q3
$40.3M Sell
1,922,230
-25,102
-1% -$699K 0.02% 1398
2022
Q2
$60.4M Buy
1,947,332
+578,671
+42% +$19.8M 0.02% 1135
2022
Q1
$56.2M Buy
1,368,661
+342,964
+33% +$15.1M 0.02% 1320
2021
Q4
$44.6M Buy
1,025,697
+39,137
+4% +$1.77M 0.01% 1492
2021
Q3
$49.4M Buy
986,560
+10,722
+1% +$649K 0.02% 1419
2021
Q2
$61.5M Sell
975,838
-73,207
-7% -$4.7M 0.02% 1265
2021
Q1
$97.5M Buy
1,049,045
+12,231
+1% +$1.25M 0.03% 851
2020
Q4
$92.9M Sell
1,036,814
-134,520
-11% -$12.3M 0.03% 800
2020
Q3
$121M Sell
1,171,334
-77,378
-6% -$8.34M 0.05% 442
2020
Q2
$98.7M Sell
1,248,712
-17,078
-1% -$1.27M 0.04% 569
2020
Q1
$73.2M Sell
1,265,790
-45,710
-3% -$2.63M 0.04% 654
2019
Q4
$70.8M Sell
1,311,500
-187,249
-12% -$10.2M 0.03% 1077
2019
Q3
$78.4M Sell
1,498,749
-139,750
-9% -$6.51M 0.03% 914
2019
Q2
$79.2M Buy
1,638,499
+45,709
+3% +$2.19M 0.03% 924
2019
Q1
$80.5M Sell
1,592,790
-96,950
-6% -$5.72M 0.03% 874
2018
Q4
$100M Sell
1,689,740
-58,081
-3% -$3.74M 0.05% 548
2018
Q3
$115M Sell
1,747,821
-288,463
-14% -$16.8M 0.04% 586
2018
Q2
$103M Sell
2,036,284
-169,280
-8% -$8.82M 0.04% 637
2018
Q1
$116M Sell
2,205,564
-40,986
-2% -$2.04M 0.05% 511
2017
Q4
$104M Buy
2,246,550
+22,352
+1% +$941K 0.04% 588
2017
Q3
$90M Buy
2,224,198
+18,486
+0.8% +$669K 0.04% 666
2017
Q2
$74.8M Buy
2,205,712
+152,029
+7% +$4.69M 0.03% 770
2017
Q1
$59.6M Buy
2,053,683
+28,365
+1% +$863K 0.03% 978
2016
Q4
$66.5M Sell
2,025,318
-20,932
-1% -$628K 0.03% 816
2016
Q3
$64.5M Sell
2,046,250
-103,565
-5% -$3.01M 0.03% 769
2016
Q2
$60.5M Buy
2,149,815
+88,071
+4% +$3.45M 0.03% 770
2016
Q1
$74.9M Buy
2,061,744
+150,099
+8% +$5.3M 0.04% 555
2015
Q4
$76.5M Buy
1,911,645
+112,452
+6% +$3.92M 0.05% 506
2015
Q3
$51.3M Buy
1,799,193
+88,543
+5% +$2.92M 0.03% 776
2015
Q2
$56.4M Buy
1,710,650
+114,788
+7% +$3.56M 0.03% 747
2015
Q1
$45.9M Buy
1,595,862
+94,703
+6% +$2.72M 0.03% 917
2014
Q4
$40.9M Buy
1,501,159
+17,742
+1% +$423K 0.03% 965
2014
Q3
$31.6M Buy
1,483,417
+7,344
+0.5% +$168K 0.02% 1107
2014
Q2
$33.2M Buy
1,476,073
+197,633
+15% +$4.6M 0.02% 1090
2014
Q1
$32.3M Buy
1,278,440
+94,047
+8% +$2.38M 0.02% 1040
2013
Q4
$27.2M Buy
1,184,393
+99,847
+9% +$2.08M 0.02% 1187
2013
Q3
$20.7M Buy
1,084,546
+33,490
+3% +$598K 0.02% 1384
2013
Q2
$15.2M Buy
+1,051,056
New +$15.2M 0.01% 1609

Other funds holding EBS